Stockholders' Equity - Summary of Company's Restricted Share Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended	6 Months Ended
Mar. 31, 2022	Jun. 30, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Beginning balance (in shares)	397	397
Granted (in shares)		0
Exercised (in shares)		(119)
Canceled/forfeited (in shares)		(3)
Expired (in shares)		(60)
Ending balance (in shares)		215
Exercisable (in shares)		209
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted average exercise price, beginning balance (in dollars per share)	$ 2.89	$ 2.89
Weighted average exercise price, granted (in dollars per share)		0
Weighted average exercise price, exercised (in dollars per share)		1.87
Weighted average exercise price, canceled/forfeited (in dollars per share)		2.24
Weighted average exercise price, expired (in dollars per share)		3.97
Weighted average exercise price, ending balance (in dollars per share)		3.19
Weighted average exercise price, exercisable (in dollars per share)		$ 3.23
Weighted-average remaining contractual term, outstanding	5 years 8 months 12 days	5 years
Weighted-average remaining contractual term, exercisable		4 years
Aggregate intrinsic value outstanding		$ 429	$ 998
Aggregate intrinsic value exercisable		$ 413

The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.